TG Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

TG Therapeutics, Inc. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 19 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 5 trademarks are registered and 12 are pending. Notable registered marks include BRIUMVI and BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV. The owner is based in New York, NY.

2 Gansevoort Street, 9th Floor

New York, NY 10014

27 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (27 results)

Trademark Classifications

TG Therapeutics, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (19 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44
Medical Services (5 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (3 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does TG Therapeutics, Inc. have?

TG Therapeutics, Inc. has 27 U.S. trademarks filed with the USPTO. Of these, 5 registered, 12 pending, 10 abandoned.

What trademark classes does TG Therapeutics, Inc. file in?

TG Therapeutics, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are TG Therapeutics, Inc.'s most well-known trademarks?

TG Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as BRIUMVI and BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV. These are among 5 currently registered trademarks in the portfolio.

What is TG Therapeutics, Inc.'s trademark registration success rate?

TG Therapeutics, Inc. has a 33% trademark registration rate, with 5 out of 15 resolved applications resulting in successful registration. Currently, 12 applications are pending review.